RSS Feeds
Search

Articles

Pharmalicensing brings you advice, commentary and analysis from industry experts.

Articles

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
Pancreatic Cancer - Pipeline Review, Q4 2010
Nov 2010 - 50 pages - $500
Metastatic Pancreatic Cancer - Pipeline Review, Q3 2011
Jul 2011 - 321 pages - $500
Sutent (Pancreatic Cancer) - Analysis and Forecasts to 2020
Oct 2011 - 32 pages - $2,000
GV1001 (Pancreatic Cancer) - Analysis and Forecasts to 2020
Oct 2011 - 25 pages - $2,000
AMG479 (Pancreatic Cancer) - Analysis and Forecasts to 2020
Oct 2011 - 26 pages - $2,000
Masitinib (Pancreatic Cancer) - Analysis and Forecasts to 2020
Oct 2011 - 34 pages - $2,000
Abraxane (Pancreatic cancer) – Analysis and Forecasts to 2020
Oct 2011 - 34 pages - $2,000
Tarceva (Pancreatic cancer) – Analysis and Forecasts to 2020
Oct 2011 - 34 pages - $2,000
GVAX (Pancreatic Cancer) - Analysis and Forecasts to 2020
Oct 2011 - 27 pages - $2,000
S-1 (Pancreatic Cancer) - Analysis and Forecasts to 2020
Oct 2011 - 28 pages - $2,000
More Related Market Research Reports >>>

Your selection

Industry sector
Drug discovery del
High throughput screening del
Therapeutic target
Oncology del
Pancreatic cancer del
Year
2010 del

Browse By

Therapeutic target
Adenocarcinoma
Pancreatic cancer exocrine

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us